The G20 & G7 Health and Development Partnership, the International Atomic Energy Agency and the Global Institute for Disease Elimination are hosting an event to explore the link between climate change and the rise of antimicrobial resistance (AMR). Strengthening partnerships among international institutions, non-government organizations, academia, the private sector, and pharmaceutical and research sectors is essential for effectively integrating AMR into climate change policies. In this event, a panel of experts will raise awareness about the linkages between AMR and climate change and will discuss actionable recommendations for mitigating the impact of climate change on AMR.
Keynote Speakers
Najat Mokhtar, Deputy Director General and Head of the Department of Nuclear Sciences and Applications, IAEA
Abdullah Algiwizani, CEO, Public Health Authority, Saudi Arabia
Panelists
Simon Bland, CEO, Global Institute for Disease Elimination
Haileyesus Getahun, Director, AMR Quadripartite Secretariat, WHO
Thomas Tayler, Head of Climate Finance, Aviva Investors
Claus Runge, SVP, Head Market Access, Public Affairs & Sustainability, Bayer AG
Ammar Abdo, Manager, Human Development, Islamic Development Bank
Key Take-Aways and Final Remarks
Hatice Beton, Executive Director, The G20 & G7 Health and Development Partnership
Moderator
Alan Donnelly, Chair, The G20 & G7 Health and Development Partnership
